Medline (MDLN) EBITDA Margin (2025 - 2026)
Medline's (MDLN) quarterly EBITDA Margin came in at 5.14% in Q2 2026, down 418.0% year-over-year from 1.62% in Q2 2025, and down 10.45% quarter-over-quarter from 5.74% in Q1 2026.
Powered by 
Analysis
Medline (MDLN) EBITDA Margin (2025 - 2026) Analysis & Trends
Medline (MDLN) has reported EBITDA Margin for 2 consecutive years, with 5.14% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 418.0% year-over-year to 5.14% in Q2 2026; TTM through Jun 2026 was 7.11%, a N/A change from a year earlier, with the FY2025 full-year figure at 7.78%, down 63.0% from the prior year.
- EBITDA Margin was 5.14% for Q2 2026 at Medline, down from 5.74% in the prior quarter.
- Over five years, EBITDA Margin peaked at 9.32% in Q2 2025 and troughed at 5.14% in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 13.31% |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 5.14% |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 20.53% |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 7.33% |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 12.93% |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 10.89% |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | -5.97% |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | -71.46% |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 5.14% |
| Mar 28, 2026 | 5.74% |
| Jun 28, 2025 | 9.32% |
| Mar 29, 2025 | 8.59% |